Apellis Pharmaceuticals, Inc. short interest in 2024
In 2024, Apellis Pharmaceuticals, Inc.'s disclosed short interest ran from 10.16% of shares outstanding on 12 Jan 2024 to 17.27% on 31 Dec 2024, a change of +7.11 percentage points. The year's high was 18.64% on 15 Nov 2024 and its low 8.49% on 29 Feb 2024, averaging 12.47% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.58 days on 30 Aug 2024. Full history: Apellis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 10.16% (12 Jan 2024)
- End of year
- 17.27% (31 Dec 2024)
- Change
- +7.11 pp
- High
- 18.64% (15 Nov 2024)
- Low
- 8.49% (29 Feb 2024)
- Average
- 12.47%
- Highest days to cover
- 19.58 (30 Aug 2024)
- SEC filings marked
- 6
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 10.16% | 5.26 | results (8-K) |
| 31 Jan 2024 | 9.00% | 6.80 | |
| 15 Feb 2024 | 8.67% | 6.83 | |
| 29 Feb 2024 | 8.49% | 7.14 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 8.94% | 7.61 | |
| 28 Mar 2024 | 8.81% | 9.50 | |
| 15 Apr 2024 | 9.00% | 9.30 | |
| 30 Apr 2024 | 10.45% | 7.13 | |
| 15 May 2024 | 10.37% | 7.54 | 10-Q filed |
| 31 May 2024 | 10.81% | 9.27 | |
| 14 Jun 2024 | 11.45% | 15.93 | |
| 28 Jun 2024 | 12.21% | 8.22 | |
| 15 Jul 2024 | 12.50% | 11.22 | |
| 31 Jul 2024 | 13.07% | 11.59 | |
| 15 Aug 2024 | 13.36% | 7.60 | 10-Q filed |
| 30 Aug 2024 | 13.28% | 19.58 | |
| 13 Sep 2024 | 12.55% | 10.93 | |
| 30 Sep 2024 | 12.53% | 6.67 | |
| 15 Oct 2024 | 17.32% | 5.51 | |
| 31 Oct 2024 | 16.71% | 9.97 | |
| 15 Nov 2024 | 18.64% | 5.21 | 10-Q filed |
| 29 Nov 2024 | 17.53% | 4.86 | |
| 13 Dec 2024 | 16.09% | 6.54 | |
| 31 Dec 2024 | 17.27% | 9.98 |
See also: Apellis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.